AstraZeneca Plc said on Friday the U.S. Food and Drug Administration had granted a breakthrough therapy label for its drug to treat a type of severe asthma, potentially speeding up its development and review.

https://ift.tt/2wYKewT support@endlesssupplies.biz (Endless Supplies .Biz) September 07, 2018 at 01:52AM
No comments:
Post a Comment